Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Policy + Initiatives

Senator Collins Urges Administration to Strengthen Response to Coronavirus

Emphasizes the unique health needs of older adults in all aspects of the domestic response, from hospital preparedness to the impact of drug shortages.

by Global Biodefense Staff
February 28, 2020
Rep. Chip Roy Letter to Trump Admin Seeks Answers on COVID-19 Risks to Joint Base San Antonio Community

U.S. Senator Susan Collins sent a letter to President Donald Trump, calling on his Administration to bolster its efforts to defend against the public health threat posed by the coronavirus.

“As the coronavirus that originated in Wuhan, China, continues to spread abroad, I write today to urge the Administration to take strong actions to protect the health of Americans here at home,” said Senator Collins in her letter.  “While I applaud the Administration for prompt containment efforts, notably restricting travel from China and invoking quarantine authorities for the first time in over 50 years, we must continue to prioritize response and preparedness efforts to protect Americans, particularly as the strategy expands not only to focus on containment but also mitigation.”

Senator Collins, a senior member of the Appropriations Committee, is working with her colleagues to quickly pass a supplemental funding bill to support the government’s response to the coronavirus. 

“While I am confident there will be bipartisan support in Congress to promptly devote the financial resources needed to meet this challenge, it is essential that there be a clear understanding of the specific funding needs if we are going to be able to unite, avoid partisanship, and give public health agencies the proper tools they need to respond,” Senator Collins wrote.  “As a member of the Appropriations Committee, I stand ready to advocate for the level of resources needed to respond to coronavirus and protect public health.”

“I stress the immediate need from the Administration for timely and accurate communication with the public,” Senator Collins continued.  “I understand many uncertainties about the virus remain, but we know it is a serious threat that has the ability to spread easily and can be deadly.  There have been inconsistencies in Administration answers this week to questions concerning the response to this outbreak, including identifying threat levels and forecasts about vaccine development.  As Vice President Pence begins to oversee the federal coronavirus response, I reiterate the need for effective coordination and leadership across all agencies and departments.”

Senator Collins, the Chairman of the Aging Committee, also urged the Administration to consider the unique health needs of older adults in all aspects of the domestic response, from hospital preparedness to the impact of drug shortages to vaccine development. 

This week, Senator Collins met with Dr. Nirav Shah, the Director of the Maine Center for Disease Control and Prevention, in her Washington, D.C., office to discuss Maine and the federal government’s ongoing response and preparedness for the coronavirus.

Read the letter below or click here for the original.


The President
The White House
1600 Pennsylvania Avenue, N.W.
Washington, DC 20500

Dear Mr. President:

As the coronavirus that originated in Wuhan, China, continues to spread abroad, I write today to urge the Administration to take strong actions to protect the health of Americans here at home. While I applaud the Administration for prompt containment efforts, notably restricting travel from China and invoking quarantine authorities for the first time in over 50 years, we must continue to prioritize response and preparedness efforts to protect Americans, particularly as the strategy expands not only to focus on containment but also mitigation.

In testimony this week before a Senate Appropriations Subcommittee, Secretary Azar outlined several priorities for an appropriate government response, including thorough identification and surveillance efforts, robust support for state and local government, investment in vaccine and therapeutic research and development, and identifying and preparing for potential supply chain challenges. While I am confident there will be bipartisan support in Congress to promptly devote the financial resources needed to meet this challenge, it is essential that there be a clear understanding of the specific funding needs if we are going to be able to unite, avoid partisanship, and give public health agencies the proper tools they need to respond.

The Maine CDC Director told me this week that the State of Maine is prepared and ready to assist in the COVID-19 response, but they require prompt resources to do so effectively. The Association of State and Territorial Health Officials estimates that $3 .1 billion in federal resources will be needed for the immediate coronavirus response, including giving state and local health departments the tools they need to prepare and respond to this threat. As a member of the Appropriations Committee, I stand ready to advocate for the level of resources needed to respond to coronavirus and protect public health.

As Chairman of the Senate Special Committee on Aging, I am also concerned that older adults abroad appear to be the group most affected by this outbreak in terms of mortality. I represent the oldest state in the country by median age. During a surge capacity event like an outbreak, older adults and those with chronic medical conditions are at particular risk. In recognition of age and health conditions affecting susceptibility, I urge the Administration to consider the unique health needs of the more than 50 million older Americans, from hospital preparedness to the impact of drug shortages to vaccine development.

Finally, I stress the immediate need from the Administration for timely and accurate communication with the public. I understand many uncertainties about the virus remain, but we know it is a serious threat that has the ability to spread easily and can be deadly. There have been inconsistencies in Administration answers this week to questions concerning the response to this outbreak, including identifying threat levels and forecasts about vaccine development. As Vice President Pence begins to oversee the federal coronavirus response, I reiterate the need for effective coordination and leadership across all agencies and departments.

I look forward to working with the Administration to combat this virus, as effectively as possible, both at home and abroad.

Sincerily,

Susan M. Collins

Tags: CoronavirusCOVID-19Magazine Edition 11 March 2020Public Health EmergencySARS-CoV-2

Related Posts

Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
State Department: Reducing Revisionist State Biological and Chemical Weapons Threats
CBRNE

State Department Sanctions Syrian Military Officials for Role in Ghouta Sarin Attack

October 24, 2022
New Framework for Livestock Disease Indemnity Valuation Proposed by USDA
Biosecurity

New Framework for Livestock Disease Indemnity Valuation Proposed by USDA

September 10, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC